000 00979 a2200313 4500
005 20250512011638.0
264 0 _c19900504
008 199005s 0 0 jpn d
022 _a0009-918X
040 _aNLM
_beng
_cNLM
100 1 _aYoshida, M
245 0 0 _a[Tetrahydroisoquinoline and parkinsonism].
_h[electronic resource]
260 _bRinsho shinkeigaku = Clinical neurology
_cDec 1989
300 _a1501-3 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aChemical Phenomena
650 0 4 _aChemistry
650 0 4 _aFemale
650 0 4 _aIsoquinolines
_xadverse effects
650 0 4 _aLevodopa
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMotor Activity
_xdrug effects
650 0 4 _aParkinson Disease, Secondary
_xchemically induced
650 0 4 _aSaimiri
650 0 4 _aTetrahydroisoquinolines
773 0 _tRinsho shinkeigaku = Clinical neurology
_gvol. 29
_gno. 12
_gp. 1501-3
999 _c2636041
_d2636041